Ginsenoside Improve Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: GinsenosideDietary Supplement: Dietary fiber fill
- Registration Number
- NCT02034136
- Lead Sponsor
- CHA University
- Brief Summary
Aim : Investigated the effects of Korean red ginseng supplementation on metabolic parameters such as cholesterol, blood pressure and glucose.
Randomized Control Trial.
- Detailed Description
Methods : A randomized, double-blind, placebo-controlled, single-center study in 60 subjects who are not taking drugs that could affect metabolic and vascular function. Subjects will be randomized into a Korean red ginseng (3.0g/d) group or placebo group for a 4-week study.
We will collect anthropometric measurements, blood for laboratory testing, inflammatory marker, hormones and mitochondrial DNA copy number.
Subject : Older than 40 years of age, presented with metabolic syndrome. Subjects were excluded if they were taking drugs that could affect metabolic and vascular function, including BP control drug, anti-diabetic drugs and lipid-lowering drugs.
Measurement : We will collect anthropometric measurements and blood for laboratory testing at the initial(week 0) and final (week 4)visits. Serum levels of blood glucose, insulin, total cholesterol, HDL-cholesterol,triglyceride, and DNA copy number of mitochondria.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- metabolic syndrome
- Taking drug for lipid-lowering, BP control and anti-diabetic.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ginsenoside Ginsenoside Ginsenoside : Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group Dietary fiber fill Dietary fiber fill Dietary fiber fill manufactured to mimic Ginsenoside tablet
- Primary Outcome Measures
Name Time Method Change from baseline in metabolic syndrome profile at week 4 Baseline and 4 weeks from intake of Ginsenoside Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight
- Secondary Outcome Measures
Name Time Method Change from baseline in hormones at week 4. Initial and 4 weeks later insulin ,cortisol, testosterone, somatomedin-c and DHEAS
Trial Locations
- Locations (1)
Bundang CHA Hospital
🇰🇷Seoul, Kyeonggi-do, Korea, Republic of